Koers Nuo Therapeutics, Inc. Other OTC
Aandelen
AURX
US67059V2097
Biotechnologie & Medisch Onderzoek
Omzet 2022 | 112K 105K | Omzet 2023 | 609K 569K | Marktkapitalisatie | 24,33 mln. 22,76 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -3 mln. -2,81 mln. | Nettowinst (verlies) 2023 | -3 mln. -2,81 mln. | EV/omzet 2022 | 543 x |
Nettoliquiditeiten 2022 | 1,72 mln. 1,61 mln. | Nettoliquiditeiten 2023 | 673K 630K | EV/omzet 2023 | 38,9 x |
K/w-verhouding 2022 |
-18,9
x | K/w-verhouding 2023 |
-7,3
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 39,31% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Jorden
CEO | Chief Executive Officer | 61 | 19-09-08 |
Peter Clausen
COO | Chief Operating Officer | 58 | 01-09-08 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
C. Eric Winzer
BRD | Director/Board Member | 67 | 30-01-09 |
David Jorden
CEO | Chief Executive Officer | 61 | 19-09-08 |
Paul D. Mintz
BRD | Director/Board Member | 75 | 07-04-17 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |